Abstract 45: Antiatherosclerotic Effects of miR-33 Inhibition: Increased Reverse Cholesterol Transport and Alternative-Activation (M2) of Macrophages
Katey J. Rayner(University of Ottawa), Kathryn J. Moore(New York University), Saj Parathath(New York University), Christine Esau(Ionis Pharmaceuticals (United States)), Janine M. van Gils(Leiden University Medical Center), Carlos Fernández‐Hernando(Yale University), Ryan E. Temel(University of Kentucky), Alistair Rayner(New York University), Aaron N. Chang(Baylor University Medical Center), Edward A. Fisher(Mount Sinai Hospital), Yajaira Suárez(Yale University), Farah Hussain(New York University), Frederick J. Sheedy(Trinity College Dublin)
Cited by 0
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k